news article details

MLN Connects® Newsletter for Thursday, July 22, 2021

COVID-19: EUA for Tocilizumab Monoclonal Antibody Product

View this edition as a: Webpage | PDF


News

  • COVID-19: EUA for Tocilizumab Monoclonal Antibody Product
  • Medicare Ground Ambulance Data Collection System FAQs
  • Wound Debridement: Comparative Billing Report in July
  • 3 Ways to Protect Your Medicare Enrollment Information
  • Americans with Disabilities Act: 31st Anniversary
  • Viral Hepatitis: Medicare Covers Preventive Services

Compliance

  • Polysomnography Services: Bill Correctly

Claims, Pricers & Codes

  • ICD-10-CM Diagnosis Code Files for FY 2022

MLN Matters® Articles

  • Changes to the Laboratory National Coverage Determination (NCD) Edit Software for October 2021
  • Implement Operating Rules - Phase III Electronic Remittance Advice (ERA) Electronic Funds Transfer (EFT): Committee on Operating Rules for Information Exchange (CORE) 360 Uniform Use of Claim Adjustment Reason Codes (CARC), Remittance Advice Remark Codes (RARC) and Claim Adjustment Group Code (CAGC) Rule - Update from Council for Affordable Quality Healthcare (CAQH) CORE
  • October 2021 Quarterly Average Sales Price (ASP) Medicare Part B Drug Pricing Files and Revisions to Prior Quarterly Pricing Files
  • Quarterly Update to the National Correct Coding Initiative (NCCI) Procedure-to-Procedure (PTP) Edits, Version 27.3, Effective October 1, 2021
  • Section 50 in Chapter 30 of Publication (Pub.) 100-04 Manual Updates
  • National Coverage Determination (NCD 110.24): Chimeric Antigen Receptor (CAR) T-cell Therapy — Revised

Publications

  • Critical Access Hospital — Revised
  • Medicare Advance Written Notices of Noncoverage — Revised
  • Rural Health Clinic — Revised

Multimedia

  • Combating Medicare Parts C and D Fraud, Waste, and Abuse Web-Based Training — Revised

Posted 7/21/2021